CA-JUNIPER-NETWORKS
22.2.2024 12:01:30 CET | Business Wire | Press release
Juniper Networks (NYSE: JNPR), a leader in secure, AI-Native Networks, today announced that it is providing KK Networks, one of the fastest growing internet Service Providers (ISPs) in Pakistan, with a scalable and resilient Cloud Metro network. The network will provide residential users with affordable internet access and an enhanced quality of experience, while also providing a sustainable services delivery platform for KK Networks (KKN). KKN is also expanding its offering with business-grade internet services using the transformed network. The new, robust Cloud Metro infrastructure will cover extensive areas of Lahore, Pakistan with plans to extend further over time.
The company has also upgraded its data centers with state-of-the-art automation software and secure, high-performance platforms from Juniper to streamline and optimize the design, deployment and operations of the network fabric. This will complement the Cloud Metro platform, further enhancing the overall user experience at scale.
KKN is a fast-growing internet service provider that has rapidly evolved to accommodate the surging demand in Pakistan for digital services. Following a four-fold increase in its user base in Lahore in just two years, KKN needed a robust metro network to handle the increasing demand on bandwidth which today serves 140,000 residential customers and growing. Juniper’s Cloud Metro solution was chosen specifically to provide a platform that can scale alongside KKN’s continued traffic growth and support the distributed nature of its user base and therefore traffic patterns.
With its previous network, internet performance would often slow during peak hours. Frequent network congestion meant that subscribers’ internet connections would often drop. With a transformed metro network that keeps up with the pace and scale of demand, KKN can now deliver reliable internet connectivity with enhanced quality of experience for its subscribers. The company is continuing a high-growth trajectory with an opportunity to bring high-performance, differentiated internet services to thousands of homes and businesses in Pakistan.
KKN has an ongoing objective to help support and enhance the digital economy in Pakistan. Approximately half of the 230 million population is still without access to broadband internet services today, according to the Pakistan Telecom Authority. The Cloud Metro network from Juniper equips KKN to create reliable, high-quality digital connections that can improve economic opportunity, build a stronger community and foster better education. Juniper Cloud Metro’s compact and efficient system design enables KKN to deliver more energy-efficient operations. Additional to improving its own operational costs, this also bolsters its ability to offer affordable broadband for customers across the region.
News Highlights
- KKN deployed the Juniper Cloud Metro solution to scale capacity, improve resiliency and deliver low-latency user experiences for residential and business services.
- High-capacity Juniper ACX7100-32C Cloud Metro routers form the aggregation network, meeting KKN’s growth requirements with a compact, power-efficient design for operational efficiency.
- The Juniper ACX710 Universal Metro Router is used for the access layer. As a compact, hardened platform, the ACX710 can be deployed indoors or outdoors. Its high port density and small footprint allow KKN to support a higher number of customers efficiently. Lower energy consumption means KKN can deliver its services more sustainably.
- KKN also uses Juniper’s AI-driven, high-performance EX2300 Ethernet Switch to extend connectivity to its business customers. The cloud-ready EX switches are easy to onboard, configure and manage, ensuring quick and easy deployment for KKN’s business customers.
- KKN uses Juniper QFX5120 switches for the data center underlay network, EVPN-VXLAN for the overlay network and EX2300s to create a data center fabric that supports up to 100GbE interfaces. This enables the network to keep pace with customer demand for content delivery, voice, video and other bandwidth-hungry services.
- KKN plans to deploy Juniper Apstra™ intent-based networking software in its product roadmap, to automate and validate the design, deployment and operation of the data center fabric to ensure reliable operations. With multi-vendor support, Apstra will empower KKN to automate and manage networks across any data center location, vendor and topology.
Supporting Quotes
“KKN is determined to improve and expand internet services across Lahore, Pakistan, to ensure that our customers have the best digital experiences. With Juniper, our new Cloud Metro network has observed 99.9 per cent uptime, delivering an accessible, high-performance digital platform to 14 regions in Lahore. With this new low-latency, resilient network, KKN can continue to grow our customer base with confidence that residential and business customers can rely on great connectivity to a sustainable network that can handle the demand.”
- Imran Ali, CEO, KK Networks
“Juniper continuously strives to enable remarkable digital experiences for our customers’ users, and the Cloud Metro solution is a perfect example of our market-leading innovation, applying cloud principles to metro networks. KK Networks is undertaking a transformative journey, upgrading from a traditional “Retro Metro” that cannot keep up with demand for today’s digital services at scale, to Juniper’s high-performance Cloud Metro infrastructure that makes sustainable, future-proof business growth possible for service providers globally.”
- AE Natarajan, Executive Vice President, Juniper Networks
Additional Resources
Juniper Solution: Cloud Metro
About Juniper Networks
Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up across the AIOps layer and our systems to fully harness the power of AI. From real-time fault isolation to proactive anomaly detection and self-driving corrective actions, it provides campus, branch, data center, and WAN operations with next-level predictability, reliability, and security. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter), LinkedIn and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240222111099/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
